Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
- PMID: 8207839
- PMCID: PMC236393
- DOI: 10.1128/JVI.68.7.4650-4655.1994
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
Abstract
Virologic and immunologic studies were performed on five patients presenting with primary human immunodeficiency virus type 1 (HIV-1) infection. CD8+ cytotoxic T lymphocyte (CTL) precursors specific for cells expressing antigens of HIV-1 Gag, Pol, and Env were detected at or within 3 weeks of presentation in four of the five patients and were detected in all five patients by 3 to 6 months after presentation. The one patient with an absent initial CTL response had prolonged symptoms, persistent viremia, and low CD4+ T-cell count. Neutralizing antibody activity was absent at the time of presentation in all five patients. These findings suggest that cellular immunity is involved in the initial control of virus replication in primary HIV-1 infection and indicate a role for CTL in protective immunity to HIV-1 in vivo.
Similar articles
-
Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.AIDS Res Hum Retroviruses. 1997 Nov 1;13(16):1383-94. doi: 10.1089/aid.1997.13.1383. AIDS Res Hum Retroviruses. 1997. PMID: 9359658
-
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.J Virol. 1999 Jul;73(7):5509-19. doi: 10.1128/JVI.73.7.5509-5519.1999. J Virol. 1999. PMID: 10364299 Free PMC article.
-
Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.J Exp Med. 1992 Dec 1;176(6):1531-42. doi: 10.1084/jem.176.6.1531. J Exp Med. 1992. PMID: 1460417 Free PMC article. Clinical Trial.
-
Cellular immune response to human immunodeficiency virus.AIDS. 2001 Feb;15 Suppl 2:S16-21. doi: 10.1097/00002030-200102002-00004. AIDS. 2001. PMID: 11424972 Review.
-
Anti-HIV adaptive immunity: determinants for viral persistence.Rev Med Virol. 2008 Sep-Oct;18(5):293-303. doi: 10.1002/rmv.577. Rev Med Virol. 2008. PMID: 18416450 Review.
Cited by
-
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.PLoS One. 2016 Apr 29;11(4):e0153849. doi: 10.1371/journal.pone.0153849. eCollection 2016. PLoS One. 2016. PMID: 27128502 Free PMC article.
-
Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine.Vaccine. 2012 Dec 14;30(52):7547-60. doi: 10.1016/j.vaccine.2012.10.042. Epub 2012 Oct 24. Vaccine. 2012. PMID: 23102976 Free PMC article.
-
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.Blood. 2012 Jan 19;119(3):745-55. doi: 10.1182/blood-2010-12-324848. Epub 2011 Dec 1. Blood. 2012. PMID: 22134167 Free PMC article.
-
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.PLoS One. 2015 Apr 9;10(4):e0122835. doi: 10.1371/journal.pone.0122835. eCollection 2015. PLoS One. 2015. PMID: 25856308 Free PMC article.
-
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.PLoS One. 2012;7(12):e50728. doi: 10.1371/journal.pone.0050728. Epub 2012 Dec 7. PLoS One. 2012. PMID: 23236388 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials